MedTrace Logo

Dose Response Trial of Pergolide for Cocaine Dependence - 1

NCT00000248 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2018-05-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Pergolide

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Robert Malcolm, M.D. · Medical University of South Carolina

Study Design

Purpose
TREATMENT

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000248 on ClinicalTrials.gov